Related Experiment Videos
[Metamemory and Parkinson's disease].
C Souchay1, R Gil, M Isingrini
1Laboratoire de Psychologie Expérimentale, Université de Tours, 3, rue des Tanneurs, 37041 Tours cedex, France. Celine.Souchay@wanadoo.fr
Revue Neurologique
|April 27, 2002
Summary
Parkinson's disease impairs memory control, leading individuals with the condition to allocate less study time. This reduced study time in Parkinson's patients partially explains their poorer memory performance compared to controls.
Area of Science:
- Cognitive Neuroscience
- Neurology
Context:
- Metamemory, the knowledge and control of one's own memory, is crucial for daily functioning.
- Metacognitive control, specifically the allocation of study time, is a key aspect of metamemory.
Purpose:
- To investigate the impact of Parkinson's disease (PD) on the allocation of study time and its relation to memory performance.
- To compare metamemory control in individuals with Parkinson's disease and healthy older adults.
Summary:
- This study examined study time allocation in 17 Parkinson's patients and 18 older controls using a readiness recall task.
- Control subjects allocated more study time per item than Parkinson's subjects.
- While both groups performed similarly in an experimenter-paced condition, controls recalled more items than PD subjects in a self-paced condition.
Impact:
- Findings suggest that altered study time allocation in Parkinson's disease contributes to observed deficits in memory performance.
- Highlights the importance of metacognitive control in understanding cognitive impairments associated with Parkinson's disease.